OR1J4

Across TCGA pan-cancer cohorts, OR1J4 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of OR1J4’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where OR1J4 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR1J4 is over-expressed in tumor.

HNSC, COAD, and BLCA are the cancer types where OR1J4 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR1J4 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Male	All	+0.176	<.001	8	view →
COAD	All	All	+0.096	<.001	7	view →
BLCA	All	All	+0.145	.009	5	view →
LUSC	Male	All	+0.246	<.001	4	view →
KIRC	All	All	+0.050	.007	3	view →
LIHC	Female	All	+0.025	.004	3	view →
STAD	All	All	+0.126	.016	2	view →
LUAD	All	All	+0.034	.040	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

OR1J4–HNSC

Open the HNSC breakdown →